{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:06:37Z","timestamp":1777629997398,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jsb.2020.107627","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:33:07Z","timestamp":1600324387000},"page":"107627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["OPG-Fc treatment partially rescues low bone mass phenotype in mature Bgn\/Fmod deficient mice but is deleterious to the young mouse skeleton"],"prefix":"10.1016","volume":"212","author":[{"given":"Vardit","family":"Kram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyam","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina M.","family":"Kilts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7763-2928","authenticated-orcid":false,"given":"Emily Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian F.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsb.2020.107627_b0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1160\/TH05-06-1335","article-title":"Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification","volume":"94","author":"Al-Fakhri","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jsb.2020.107627_b0010","doi-asserted-by":"crossref","first-page":"107R","DOI":"10.1093\/glycob\/cwf065","article-title":"Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases","volume":"12","author":"Ameye","year":"2002","journal-title":"Glycobiology"},{"key":"10.1016\/j.jsb.2020.107627_b0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1096\/fj.01-0848com","article-title":"Abnormal collagen fibrils in tendons of biglycan\/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis","volume":"16","author":"Ameye","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jsb.2020.107627_b0020","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jcb.21559","article-title":"Heparin inhibits osteoclastic differentiation and function","volume":"103","author":"Ariyoshi","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jsb.2020.107627_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jsb.2020.107627_b0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/pr.2012.118","article-title":"High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice","volume":"72","author":"Bargman","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0035","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jsb.2020.107627_b0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.NPR.0000391178.47878.73","article-title":"Denosumab (Prolia): A new option in the treatment of osteoporosis","volume":"36","author":"Belavic","year":"2011","journal-title":"Nurse Pract."},{"key":"10.1016\/j.jsb.2020.107627_b0050","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00018-008-8019-0","article-title":"The leucine-rich repeat structure","volume":"65","author":"Bella","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jsb.2020.107627_b0055","doi-asserted-by":"crossref","unstructured":"Bi, Y., Nielsen, K.L., Kilts, T.M., Yoon, A., M, A.K., Wimer, H.F., Greenfield, E.M., Heegaard, A.M., Young, M.F., 2006. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38, 778-786.","DOI":"10.1016\/j.bone.2005.11.005"},{"key":"10.1016\/j.jsb.2020.107627_b0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3758\/s13428-017-0918-2","article-title":"Effect of variance ratio on ANOVA robustness: Might 1.5 be the limit?","volume":"50","author":"Blanca","year":"2018","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.jsb.2020.107627_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000091376","article-title":"Variation in mineral properties in normal and mutant bones and teeth","volume":"181","author":"Boskey","year":"2005","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jsb.2020.107627_b0070","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11914-017-0380-1","article-title":"Denosumab: an emerging therapy in pediatric bone disorders","volume":"15","author":"Boyce","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.jsb.2020.107627_b0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2020.107627_b0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","article-title":"Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial","volume":"24","author":"Brown","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1677\/JOE-10-0209","article-title":"Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading","volume":"207","author":"Callewaert","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsb.2020.107627_b0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jsb.2020.107627_b0100","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/dvdy.20833","article-title":"Recent advances in craniofacial morphogenesis","volume":"235","author":"Chai","year":"2006","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jsb.2020.107627_b0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1302\/0301-620X.57B1.36","article-title":"Observations on the induction of bone in soft tissues","volume":"57","author":"Chalmers","year":"1975","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.jsb.2020.107627_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.matbio.2014.01.004","article-title":"Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly","volume":"35","author":"Chen","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0115","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1096\/fj.03-0899com","article-title":"The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation","volume":"18","author":"Chen","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jsb.2020.107627_b0120","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1359\/jbmr.2002.17.7.1180","article-title":"Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues","volume":"17","author":"Corsi","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0125","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsb.2020.107627_b0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jor.20469","article-title":"The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta","volume":"26","author":"Delos","year":"2008","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.matbio.2006.04.004","article-title":"Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation","volume":"25","author":"Droguett","year":"2006","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0140","first-page":"166","article-title":"Gender specific LRP5 influences on trabecular bone structure and strength","volume":"7","author":"Dubrow","year":"2007","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.jsb.2020.107627_b0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jramc-2014-000277","article-title":"Heterotopic ossification: a systematic review","volume":"161","author":"Edwards","year":"2015","journal-title":"J. R. Army Med. Corps"},{"key":"10.1016\/j.jsb.2020.107627_b0150","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","article-title":"Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer","volume":"26","author":"Ellis","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsb.2020.107627_b0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1177\/0022034511421930","article-title":"Role of subchondral bone during early-stage experimental TMJ osteoarthritis","volume":"90","author":"Embree","year":"2011","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1369\/jhc.5A6650.2005","article-title":"Fibromodulin-deficient mice display impaired collagen fibrillogenesis in predentin as well as altered dentin mineralization and enamel formation","volume":"54","author":"Goldberg","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.jsb.2020.107627_b0165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1096\/fasebj.6.3.1740236","article-title":"Proteoglycans: many forms and many functions","volume":"6","author":"Hardingham","year":"1992","journal-title":"FASEB J."},{"issue":"Pt 2","key":"10.1016\/j.jsb.2020.107627_b0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/bj3020527","article-title":"Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta","volume":"302","author":"Hildebrand","year":"1994","journal-title":"Biochem. J."},{"issue":"50","key":"10.1016\/j.jsb.2020.107627_b0175","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1331\/JAPhA.2010.10536","article-title":"New drugs: Denosumab, dienogest\/estradiol valerate, and polidocanol","volume":"2003","author":"Hussar","year":"2010","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.jsb.2020.107627_b0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10409239709108551","article-title":"The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth","volume":"32","author":"Iozzo","year":"1997","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1096\/fasebj.10.5.8621059","article-title":"Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function","volume":"10","author":"Iozzo","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.jsb.2020.107627_b0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4140\/TCP.n.2018.142","article-title":"Effects of denosumab after treatment discontinuation: a review of the literature","volume":"33","author":"Iranikhah","year":"2018","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.jsb.2020.107627_b0195","first-page":"351","article-title":"Neurogenic heterotopic ossification","volume":"66","author":"Jensen","year":"1987","journal-title":"Am. J. Phys. Med."},{"key":"10.1016\/j.jsb.2020.107627_b0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2010.01.001","article-title":"The role of small leucine-rich proteoglycans in collagen fibrillogenesis","volume":"29","author":"Kalamajski","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0205","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1469-1809.2008.00447.x","article-title":"Contribution of gender-specific genetic factors to osteoporosis risk","volume":"72","author":"Karasik","year":"2008","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.jsb.2020.107627_b0210","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1359\/jbmr.060905","article-title":"RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis","volume":"21","author":"Kim","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00223-005-0039-2","article-title":"Compartmental bone morphometry in the mouse femur: reproducibility and resolution dependence of microtomographic measurements","volume":"77","author":"Kohler","year":"2005","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jsb.2020.107627_b0220","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0225","doi-asserted-by":"crossref","first-page":"12627","DOI":"10.1038\/s41598-017-12651-6","article-title":"Small leucine rich proteoglycans, a novel link to osteoclastogenesis","volume":"7","author":"Kram","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsb.2020.107627_b0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF00731261","article-title":"The structure of the keratan sulphate chains attached to fibromodulin isolated from bovine tracheal cartilage: oligosaccharides generated by keratanase II digestion","volume":"12","author":"Lauder","year":"1995","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.jsb.2020.107627_b0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/1008-682X.122356","article-title":"Androgens and estrogens in skeletal sexual dimorphism","volume":"16","author":"Laurent","year":"2014","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.jsb.2020.107627_b0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2007-11-124164","article-title":"Role of decorin in the antimyeloma effects of osteoblasts","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jsb.2020.107627_b0245","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jsb.2020.107627_b0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/iub.167","article-title":"A comparative biochemical analysis of glycosaminoglycans and proteoglycans in human orthotopic and heterotopic bone","volume":"61","author":"Mania","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jsb.2020.107627_b0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsb.2006.01.016","article-title":"Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans","volume":"155","author":"McEwan","year":"2006","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0260","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2011.01.022","article-title":"Role of glycosaminoglycans of biglycan in BMP-2 signaling","volume":"405","author":"Miguez","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsb.2020.107627_b0265","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.179.1.266","article-title":"Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection","volume":"179","author":"Miller","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsb.2020.107627_b0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-0-387-34133-0_7","article-title":"Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation","volume":"585","author":"Mochida","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jsb.2020.107627_b0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/11203300-000000000-00000","article-title":"Denosumab: a review of its use in the treatment of postmenopausal osteoporosis","volume":"28","author":"Moen","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jsb.2020.107627_b0280","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00198-007-0363-7","article-title":"The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys","volume":"18","author":"Ominsky","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jsb.2020.107627_b0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1359\/jbmr.080109","article-title":"RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats","volume":"23","author":"Ominsky","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00223-005-0161-1","article-title":"The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism","volume":"78","author":"Padagas","year":"2006","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jsb.2020.107627_b0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000166209","article-title":"Osteoporosis: an age-related and gender-specific disease\u2013a mini-review","volume":"55","author":"Pietschmann","year":"2009","journal-title":"Gerontology"},{"key":"10.1016\/j.jsb.2020.107627_b0300","doi-asserted-by":"crossref","unstructured":"Reid, I.R., Miller, P.D., Brown, J.P., Kendler, D.L., Fahrleitner-Pammer, A., Valter, I., Maasalu, K., Bolognese, M.A., Woodson, G., Bone, H., Ding, B., Wagman, R.B., San Martin, J., Ominsky, M.S., Dempster, D.W., Denosumab Phase 3 Bone Histology Study, G., 2010. Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J. Bone Miner. Res. 25, 2256-2265.","DOI":"10.1002\/jbmr.149"},{"key":"10.1016\/j.jsb.2020.107627_b0305","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3550577","article-title":"Murine fibromodulin: cDNA and genomic structure, and age-related expression and distribution in the knee joint","volume":"355","author":"Saamanen","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsb.2020.107627_b0310","doi-asserted-by":"crossref","first-page":"21305","DOI":"10.1074\/jbc.R800020200","article-title":"Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction","volume":"283","author":"Schaefer","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2020.107627_b0315","first-page":"346","article-title":"Heterotopic ossification","volume":"43","author":"Shehab","year":"2002","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jsb.2020.107627_b0320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jsb.2020.107627_b0325","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1055\/s-0031-1295463","article-title":"OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers","volume":"43","author":"Sipos","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0330","doi-asserted-by":"crossref","first-page":"32634","DOI":"10.1016\/S0021-9258(18)31681-8","article-title":"Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity","volume":"269","author":"Takeuchi","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsb.2020.107627_b0335","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bbrc.2006.06.120","article-title":"Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK","volume":"347","author":"Theoleyre","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsb.2020.107627_b0340","first-page":"312","article-title":"Experimental myositis ossificans: cartilage and bone formation in muscle in response to a diffusible bone matrix-derived morphogen","volume":"102","author":"Urist","year":"1978","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jsb.2020.107627_b0345","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22203\/eCM.v006a02","article-title":"Differential roles for small leucine-rich proteoglycans in bone formation","volume":"6","author":"Waddington","year":"2003","journal-title":"Eur. Cell Mater."},{"key":"10.1016\/j.jsb.2020.107627_b0350","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000091375","article-title":"Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis","volume":"181","author":"Wadhwa","year":"2005","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jsb.2020.107627_b0355","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0022034514541126","article-title":"Fibromodulin and biglycan modulate periodontium through TGFbeta\/BMP signaling","volume":"93","author":"Wang","year":"2014","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jsb.2020.107627_b0360","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35076601","article-title":"Genetics of craniofacial development and malformation","volume":"2","author":"Wilkie","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jsb.2020.107627_b0365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mce.2014.09.018","article-title":"Biglycan is a novel binding partner of fibroblast growth factor receptor 3c (FGFR3c) in the human testis","volume":"399","author":"Winge","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsb.2020.107627_b0370","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1182\/blood.V98.7.2124","article-title":"Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1)","volume":"98","author":"Xaus","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jsb.2020.107627_b0375","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/1746","article-title":"Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice","volume":"20","author":"Xu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsb.2020.107627_b0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-beta by the proteoglycan decorin","volume":"346","author":"Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jsb.2020.107627_b0385","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsb.2020.107627_b0390","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsb.2020.107627_b0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086757","article-title":"Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells","volume":"9","author":"Zanotti","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsb.2020.107627_b0400","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0100-879X2012007500049","article-title":"Experimental model of heterotopic ossification in Wistar rats","volume":"45","author":"Zotz","year":"2012","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Journal of Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847720302008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847720302008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T03:19:38Z","timestamp":1760930378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047847720302008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1047847720302008"],"URL":"https:\/\/doi.org\/10.1016\/j.jsb.2020.107627","relation":{},"ISSN":["1047-8477"],"issn-type":[{"value":"1047-8477","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OPG-Fc treatment partially rescues low bone mass phenotype in mature Bgn\/Fmod deficient mice but is deleterious to the young mouse skeleton","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsb.2020.107627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107627"}}